Sandoz receives approval in Portugal for innovative respiratory inhaler AirFluSal® Forspiro®

  • Portuguese Health Authority grants marketing authorization for AirFluSal® Forspiro®
  • Approval for 50-250 and 50-500µg dosage forms
  • AirFluSal Forspiro already launched in four European countries and South Korea

Holzkirchen, October 09, 2014 – Sandoz announces today that the Portuguese Health Authority (Infarmed) has granted marketing authorization for AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and/or chronic obstructive pulmonary disease (COPD).

AirFluSal Forspiro has now been approved in a total of 10 …

/by

US celebrates 30 years of rapid generics growth

October 01, 2014 – 30 years ago, when President Ronald Reagan signed the legislation that would lay the basis for today’s US generics industry, even the law’s biggest fans never guessed quite how successful it would be.

One estimate – optimistic at the time – was that the new legislation, commonly known today as the Hatch Waxman Act, could save Americans a total of USD 1 billion.

A study published this year by the IMS Institute for …

/by

US celebrates 30 years of rapid generics growth

October 01, 2014 – 30 years ago, when President Ronald Reagan signed the legislation that would lay the basis for today’s US generics industry, even the law’s biggest fans never guessed quite how successful it would be.

One estimate – optimistic at the time – was that the new legislation, commonly known today as the Hatch Waxman Act, could save Americans a total of USD 1 billion.

A study published this year by the IMS Institute for …

/by